{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:25:19Z","timestamp":1787970319703,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jaip.2017.03.032","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T15:12:35Z","timestamp":1494342755000},"page":"1650-1656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["\u201cTreating Through\u201d Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas"],"prefix":"10.1016","volume":"5","author":[{"given":"Axel","family":"Trautmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Stoevesandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.03.032_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.iac.2004.03.010","article-title":"Classification and epidemiology of hypersensitivity drug reactions","volume":"24","author":"Demoly","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.03.032_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.032_bib3","first-page":"CD005646","article-title":"Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV\/AIDS in patients with previous history of hypersensitivity to cotrimoxazole","volume":"2","author":"Lin","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2017.03.032_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5415\/apallergy.2014.4.3.156","article-title":"A\u00a0retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy","volume":"4","author":"Thong","year":"2014","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaip.2017.03.032_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.iac.2009.04.005","article-title":"Approach to the patient with drug allergy","volume":"29","author":"Schnyder","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.03.032_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.mcna.2010.04.007","article-title":"Danger signs in drug hypersensitivity","volume":"94","author":"Scherer","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaip.2017.03.032_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tox.2004.12.036","article-title":"Symptoms and danger signs in acute drug hypersensitivity","volume":"209","author":"Bircher","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jaip.2017.03.032_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0753-3322(00)88640-0","article-title":"The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study","volume":"54","author":"Bonfanti","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaip.2017.03.032_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/323353","article-title":"Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ","volume":"184","author":"Leoung","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaip.2017.03.032_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/S1413-86702002000600002","article-title":"A\u00a0randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides","volume":"6","author":"Straatmann","year":"2002","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jaip.2017.03.032_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000063387","article-title":"Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone","volume":"204","author":"Nijsten","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2017.03.032_bib12","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1016\/j.ijcard.2013.05.051","article-title":"A\u00a0strategy of \u2018treating through\u2019 a prasugrel-induced rash","volume":"168","author":"Yang","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaip.2017.03.032_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0404.2005.00381.x","article-title":"Lamotrigine-induced rash-worth a rechallenge","volume":"111","author":"Codrea","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jaip.2017.03.032_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s40265-015-0434-6","article-title":"Expert consensus on the management of adverse events from EGFR tyrosine kinase inhibitors in the UK","volume":"75","author":"Califano","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jaip.2017.03.032_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/jdv.13443","article-title":"Profile of vemurafenib-induced severe skin toxicities","volume":"30","author":"Peuvrel","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2017.03.032_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jaip.2017.03.032_bib17","first-page":"357","article-title":"The drug hypersensitivity syndrome: what is the pathogenesis?","volume":"137","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2017.03.032_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.mcna.2010.03.004","article-title":"Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome","volume":"94","author":"Kano","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaip.2017.03.032_bib19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2017.03.032_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00105-011-2233-7","article-title":"[Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome]","volume":"63","author":"M\u00fcller","year":"2012","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaip.2017.03.032_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2017.03.032_bib22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions\u2014an EAACI position paper of the Drug Allergy Interest Group","volume":"68","author":"Scherer","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.032_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/157488606777934413","article-title":"Rapid desensitization of hypersensitivity reactions to chemotherapy agents","volume":"1","author":"Castells","year":"2006","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jaip.2017.03.032_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.aller.2010.06.008","article-title":"Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing","volume":"39","author":"Seitz","year":"2011","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaip.2017.03.032_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000199720","article-title":"Allergy diagnostic testing in clindamycin-induced skin reactions","volume":"149","author":"Seitz","year":"2009","journal-title":"Int Arch Allergy Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817302271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817302271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:14:43Z","timestamp":1761974083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817302271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2213219817302271"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.03.032","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTreating Through\u201d Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}